How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Yohimbe Extract Market
- By Product Form: Powder, Capsules, Tablets, Liquid Extract, Tincture
- By Application: Dietary Supplements, Pharmaceuticals, Functional Foods & Beverages, Cosmetics & Personal Care
- By Extraction Method: Ethanol Extraction, Water Extraction, Supercritical CO2 Extraction, Solvent Extraction
- By End User: Men's Health Products, Sports Nutrition, Weight Management Products, Sexual Wellness Products
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Powder leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 274 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Yohimbe Extract Market report
A complete, evidence-based study - 11 chapters and 115 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Form 5
Application 4
Extraction Method 4
End User 4
Companies profiled
Sabinsa Corporation
Indena S.p.A.
Naturex (a Givaudan company)
Euromed S.A.
Nutraceutical Corporation
Hunan Nutramax Inc.
Xi'an Natural Field Bio-Technique Co. Ltd.
Glanbia Nutritionals
Martin Bauer Group
Amax NutraSource
Herbalife Nutrition
NOW Foods
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Sabinsa Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Indena S.p.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Naturex (a Givaudan company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Euromed S.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nutraceutical Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Hunan Nutramax Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Xi'an Natural Field Bio-Technique Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Glanbia Nutritionals
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Martin Bauer Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Amax NutraSource
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Herbalife Nutrition
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →NOW Foods
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →BASF SE
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Arjuna Natural Extracts Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Plantextrakt GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,543M by 2033 · 11.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Powder51.7
- Capsules12.9
- Tablets15.7
- Liquid Extract8.9
- Tincture10.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,485M → $3,582M · 11.6%
Europe$1,035M → $2,636M · 12.4%
Asia Pacific$945.3M → $2,037M · 10.1%
Latin America$585.2M → $1,503M · 12.5%
Middle East and Africa$450.1M → $1,162M · 12.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.192026
11.182027
11.202028
11.212029
11.232030
11.232031
11.252032
11.262033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Sabinsa Corporation30.1
- Indena S.p.A.10.3
- Naturex (a Givaudan company)5.1
- Euromed S.A.5.2
- Nutraceutical Corporation15.9
- Hunan Nutramax Inc.5.5
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form17.8%
Application29.1%
Extraction Method34.2%
End User19.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.8
- Europe24.1
- Asia Pacific18.7
- Latin America13.8
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Sabinsa Corporation | 95 | 78 | 91 | 83 | 88 | 92 | 88 |
| Indena S.p.A. | 92 | 78 | 89 | 72 | 79 | 75 | 81 |
| Naturex (a Givaudan company) | 83 | 84 | 66 | 74 | 86 | 82 | 79 |
| Euromed S.A. | 82 | 65 | 72 | 79 | 62 | 58 | 70 |
| Nutraceutical Corporation | 67 | 57 | 66 | 58 | 66 | 63 | 63 |
| Hunan Nutramax Inc. | 50 | 57 | 46 | 65 | 65 | 47 | 55 |
| Xi'an Natural Field Bio-Technique Co. Ltd. | 58 | 41 | 41 | 63 | 47 | 53 | 51 |
| Glanbia Nutritionals | 49 | 46 | 54 | 45 | 42 | 60 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Sabinsa Corporation
- Indena S.p.A.
- Naturex (a Givaudan company)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Sabinsa Corporation | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Indena S.p.A. | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Naturex (a Givaudan company) | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Euromed S.A. | ✓ | − | ◐ | ◐ | ◐ | − |
| Nutraceutical Corporation | − | ◐ | ◐ | − | − | ◐ |
| Hunan Nutramax Inc. | ◐ | ◐ | ◐ | − | ◐ | − |
| Xi'an Natural Field Bio-Technique Co. Ltd. | − | − | ◐ | − | − | ◐ |
| Glanbia Nutritionals | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Sabinsa Corporation88
2Indena S.p.A.81
3Naturex (a Givaudan company)79
4Euromed S.A.70
5Nutraceutical Corporation63
6Hunan Nutramax Inc.55
7Xi'an Natural Field Bio-Technique Co. Ltd.51
8Glanbia Nutritionals49
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Sabinsa CorporationIndena S.p.A.Naturex (a Givaudan company)
Challenger1
Strong scale, closing on the leaders.
Euromed S.A.
Contender1
Focused players with pockets of strength.
Nutraceutical Corporation
Niche3
Specialists in a single segment or region.
Hunan Nutramax Inc.Xi'an Natural Field Bio-Technique Co. Ltd.Glanbia Nutritionals
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across Yohimbe Extract Market — a $247M beachhead inside a $3.82B market.
Beachhead (SOM)$247Mobtainable near-term
Serviceable (SAM)$1.55Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Powder
Best fit — highest urgency & budget in Product Form.
Economic buyer78 fit
Capsules
Strong fit — clear ROI and a fast path to value.
End user70 fit
Tablets
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Extraction Method
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve23%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Yohimbe Extract Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified21%
Evaluation12%
Closed-won7%
$20.2KCAC
$77KLTV
3.8:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Yohimbe Extract Market is a resilient opportunity — $5.88B by 2033, compounding at 5.4%.
TAM · 2025$3.86Btoday
TAM · 2033$5.88Bforecast
CAGR5.4%2027–2033
Cumulative$43.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.88BTotal addressable market
SAM$2.06BServiceable available market
SOM$420MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.88BLarge & growingTAM by 2033 at 5.4% CAGR
$2.06BServiceable nowreachable with today’s model
$420MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.59BBear3.5% CAGR
$5.88BBase5.4% CAGR
$7.53BBull7.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Yohimbe Extract Market — a $3.65B market by 2033. Plan: grow share from 6.5% to 11.6%.
Market size · 2033$3.65Btotal addressable
Market CAGR9.5%2027–2033
Target share11.6%from 6.5% today
Revenue ambition$423Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.5% | 11.6% | On track |
| Revenue | $229M | $423M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 30.4% | 39.7% | On track |
| Customer retention | 84.9% | 95.7% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $58M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Yohimbe Extract Market conversation — a $1.48B market you can size, segment and defend in minutes.
Market size · 2033$1.48Btotal opportunity
Growth7.5%CAGR to 2033
Addressable buyers1,749+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 3 mopayback period
$82K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Sabinsa CorporationIndena S.p.A.Naturex (a Givaudan company)Euromed S.A.Nutraceutical CorporationHunan Nutramax Inc.Xi'an Natural Field Bio-Technique Co. Ltd.Glanbia Nutritionals+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Yohimbe Extract Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Yohimbe Extract Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →YME1L1 Antibody Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportYIPF1 Antibody Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportY Infusion Connector Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportYellow Nail Syndrome Treatment Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportYellow Fever Vaccines Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportYellow Fever Vaccination Market
Market size, share, segmentation and regional forecast.
$423M market · 2025 base year
View reportYellow and White Dextrins Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportYeast two-hybrid System Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportYeast Protein Expression Service Market
Yeast Protein Expression Service Market is valued at USD 420 Million in 2025 and is expected to…
$420M market · 2025 base year
View reportYeast Peptone Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportYeast Extract Peptone Dextrose Mediums Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportYeast Expression System Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.